A rate-limiting enzyme in BCAA catabolism, named BCKDK, has also been reported to promote colorectal cancer tumorigenesis via upregulating the MAPK pathway by phosphorylating MEK at Ser221 (Xue et al., 2017). The gene discussed is MAP2K7; the disease is colorectal cancer.